Hovione Licenses Inhaler Technology for Influenza Drug to Sankyo Company, Ltd. (SKXOF.PK) and Biota Holdings Limited (BTA.AX)
3/5/2007 12:22:01 PM
More...
|
Daiichi Sankyo, Inc. Subsidiary Applies For Additional Indication For Fentanyl Injection
10/2/2006 10:21:00 AM
More...
|
Ajinomoto And Sankyo Company, Ltd. (SKXOF.PK) In Joint Development, Manufacture And Marketing Of AJD101, New Diabetes Drug
8/31/2006 9:40:59 AM
More...
|
Sankyo Company, Ltd. (SKXOF.PK) To Manufacture, Distribute Olmetic Antihypertensive Drug In China
8/14/2006 1:35:25 PM
More...
|
Sankyo To Manufacture, Distribute Olmetic Antihypertensive Drug In China
8/4/2006 5:51:40 PM
More...
|
Sankyo Company, Ltd. (SKXOF.PK) To Launch Osteoporosis Treatment Drug In Europe
7/19/2006 2:19:19 PM
More...
|
Sankyo Company, Ltd. (SKXOF.PK) Selected Evotec OAI (Germany) (EVTG.F) As Assay Development And Screening Partner
4/27/2006 10:28:30 AM
More...
|
Exelixis, Inc. (EXEL) And Sankyo Company, Ltd. (SKXOF.PK) Sign Collaboration Agreement To Develop Novel Therapies For Cardiovascular Disease; $20 Million Upfront Payment
3/20/2006 10:35:46 AM
More...
|
MorphoSys AG And Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance To Develop Novel Antibody Therapies
3/16/2006 12:39:34 PM
More...
|
Eli Lilly and Company (LLY) And Sankyo Company, Ltd. (SKXOF.PK) Release: Study Shows More Potent And More Reliable Platelet Inhibition wWth Prasugrel Compared To Clopidogrel Even In Patients With More Reactive Platelets
3/14/2006 2:33:55 PM
More...
|
|